Professional
Added to YB: 2025-07-11
Pitch date: 2025-07-09
IPA [neutral]
ImmunoPrecise Antibodies Ltd.
-7.81%
current return
Author Info
Pernas Research is a former CIO of a $3.5B fund that now share actionable stock research. Sign up for the newsletter.
Company Info
ImmunoPrecise Antibodies Ltd. operates as a techbio company. It leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies; and support the discovery and development of therapeutic antibodies.
Market Cap
$110.2M
Pitch Price
$1.92
Price Target
N/A
Dividend
N/A
EV/EBITDA
-10.38
P/E
-1.48
EV/Sales
4.59
Sector
Life Sciences Tools and Services
Category
growth
Pernas Research More Research Needed On: ImmunoPrecise Antibodies Ltd.
IPA more research needed: CRO with AI biotherapeutics segment. 2022 BioStrand acquisition added epitope mapping expertise/data. Integrates wet-lab with computational testing to accelerate drug research. Has legacy biotech clients but AI platform lacks traction. $80M market cap at $1.76.
Read full article (1 min)